Literature DB >> 24009204

Influence of induced ciprofloxacin resistance on efflux pump activity of Klebsiella pneumoniae.

Hai-qin Zhong1, Shun Zhang, Hong Pan, Ting Cai.   

Abstract

OBJECTIVE: The efflux pump (EP) is one of the major mechanisms of antibiotic resistance in Klebsiella pneumoniae. However, there are few reports on the effect of the abuse of antibiotic use on the activity of EPs. To determine whether the use of low efficacy antibiotics has any effect on the activity of EPs and induces drug resistance in K. pneumoniae, we investigated the effect of ciprofloxacin on the activity of EPs in K. pneumoniae strains.
METHODS: Sixteen susceptible K. pneumoniae strains were isolated from patients and their minimum inhibitory concentrations (MICs) of ciprofloxacin were measured in the absence and presence of the pump inhibitor carbonyl cyanide m-chlorophenyl hydrazone (CCCP). The strains were then induced with a gradient of ciprofloxacin until the MICs of the strains showed no further increase, to obtain induced resistant strains. The EP activities of the strains before and after induction were compared using EP inhibition and ethidium bromide (EtBr) accumulation assays.
RESULTS: The MIC values of the strains were 16‒256 times higher after induction than before induction. In the presence of CCCP, the MIC values of 50% of the induced strains were 2‒4-fold lower than that in the absence of this inhibitor. The EtBr accumulation assay showed that the fluorescence of EtBr in the induced cells was lower than that in the cells before induction.
CONCLUSIONS: EPs are widespread in susceptible and drug-resistant K. pneumoniae strains. Induction with ciprofloxacin may increase the activity of EPs in K. pneumoniae. The EtBr accumulation assay is more sensitive than the EP inhibition assay in evaluating the activity of EPs in K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24009204      PMCID: PMC3773555          DOI: 10.1631/jzus.B1200221

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  17 in total

Review 1.  Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.

Authors:  A Simon Lynch
Journal:  Biochem Pharmacol       Date:  2005-11-14       Impact factor: 5.858

2.  Assessment of the activity of RND-type multidrug efflux pumps in Pseudomonas aeruginosa using tetraphenylphosphonium ions.

Authors:  Rimantas Daugelavicius; Andrius Buivydas; Ana Sencilo; Dennis H Bamford
Journal:  Int J Antimicrob Agents       Date:  2010-05-21       Impact factor: 5.283

Review 3.  Antibiotic efflux pumps.

Authors:  F Van Bambeke; E Balzi; P M Tulkens
Journal:  Biochem Pharmacol       Date:  2000-08-15       Impact factor: 5.858

4.  [Multidrug-resistant Klebsiella pneumoniae, predisposing factors and associated mortality in a tertiary-care hospital in Colombia].

Authors:  Lina M Echeverri-Toro; Zulma V Rueda; Wilmar Maya; Yuli Agudelo; Sigifredo Ospina
Journal:  Rev Chilena Infectol       Date:  2012-04       Impact factor: 0.520

Review 5.  Plasmid-mediated quinolone resistance: an update.

Authors:  José Manuel Rodríguez-Martínez; María Eliecer Cano; Carmen Velasco; Luis Martínez-Martínez; Alvaro Pascual
Journal:  J Infect Chemother       Date:  2010-10-01       Impact factor: 2.211

Review 6.  Extended-spectrum beta-lactamase-producing organisms.

Authors:  M E Falagas; D E Karageorgopoulos
Journal:  J Hosp Infect       Date:  2009-07-10       Impact factor: 3.926

7.  The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.

Authors:  Renaud Chollet; Jacqueline Chevalier; André Bryskier; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

Authors:  Gian Carlo Schito; Kurt G Naber; Henry Botto; Juan Palou; Teresita Mazzei; Laura Gualco; Anna Marchese
Journal:  Int J Antimicrob Agents       Date:  2009-06-07       Impact factor: 5.283

Review 9.  Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria.

Authors:  Jean-Marie Pagès; Leonard Amaral
Journal:  Biochim Biophys Acta       Date:  2008-12-25

10.  Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli.

Authors:  Laura Paixão; Liliana Rodrigues; Isabel Couto; Marta Martins; Pedro Fernandes; Carla C C R de Carvalho; Gabriel A Monteiro; Filipe Sansonetty; Leonard Amaral; Miguel Viveiros
Journal:  J Biol Eng       Date:  2009-10-16       Impact factor: 4.355

View more
  4 in total

1.  Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant Klebsiella pneumoniae clinical strains.

Authors:  Katlego Kopotsa; Nontombi M Mbelle; John Osei Sekyere
Journal:  Microb Genom       Date:  2020-11-10

2.  A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable Streptomyces Isolated from Cave Moonmilk Deposits.

Authors:  Marta Maciejewska; Delphine Adam; Loïc Martinet; Aymeric Naômé; Magdalena Całusińska; Philippe Delfosse; Monique Carnol; Hazel A Barton; Marie-Pierre Hayette; Nicolas Smargiasso; Edwin De Pauw; Marc Hanikenne; Denis Baurain; Sébastien Rigali
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

3.  Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.

Authors:  Jeongjin Kim; Ara Jo; Ekachai Chukeatirote; Juhee Ahn
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-12-09       Impact factor: 3.944

4.  Phytochemical Composition and Anti-Efflux Pump Activity of Hydroalcoholic, Aqueous, and Hexane Extracts of Artemisia tournefortiana in Ciprofloxacin-Resistant Strains of Salmonella enterica Serotype Enteritidis.

Authors:  Marjan Khosravani; Mohammad Mehdi Soltan Dallal; Mehdi Norouzi
Journal:  Iran J Public Health       Date:  2020-01       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.